Syngene International Stock Screener | Share Price & Fundamental Analysis
SYNGENE
Healthcare Technology
Screen Syngene International share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹655.40
▼
-3.00 (-0.46%)
Share Price BSE
₹654.95
▼
-3.15 (-0.48%)
Market Cap
₹26,199.10 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
5.53
EPS (TTM)
₹12.35
Dividend Yield
0.19%
Debt to Equity
0.13
52W High
₹877.80
52W Low
₹610.10
Operating Margin
34.00%
Profit Margin
17.65%
Revenue (TTM)
₹1,037.00
EBITDA
₹363.00
Net Income
₹183.00
Total Assets
₹6,796.00
Total Equity
₹4,727.00
Syngene International Share Price History - Stock Screener Chart
Screen SYNGENE historical share price movements with interactive charts. Analyze price trends and patterns.
Syngene International Company Profile - Fundamental Screener
Screen Syngene International company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SYNGENE shares.
Syngene International Limited is an integrated research, development, and manufacturing services company headquartered in India. It serves global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors. The company operates across four business divisions: Discovery Services, Development Services, Manufacturing Services, and Dedicated Centers. With approximately 6000 scientists, Syngene has facilities spanning 2.2 million sq. ft. in Bangalore, Hyderabad, and Mangalore. It provides end-to-end services within Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO). Syngene offers various platforms and services including drug discovery, development capabilities, custom synthesis, process R&D, cGMP manufacturing, and clinical development services. The company has partnerships and collaborations with multiple global pharmaceutical and healthcare companies, expanding its research and manufacturing capabilities over the years.
Sector
Healthcare
Industry
Healthcare Technology
Sub-Sector
Healthcare Technology
Segment
E
Chairperson/CEO
Kiran Mazumdar Shaw
ISIN
INE398R01022
Website
https://www.syngeneintl.com
Syngene International Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen SYNGENE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Total Assets | 6,796 | 6,152 | 5,831 | 5,564 | 4,883 | 4,163 | 3,704 | 3,189 |
| Current Assets | 2,287 | 1,959 | 2,425 | 2,206 | 1,807 | 1,613 | 1,764 | 1,720 |
| Fixed Assets | 2,802 | 2,850 | 2,667 | 2,393 | 2,201 | 2,020 | 1,377 | 1,030 |
| Liabilities | ||||||||
| Total Liabilities | 6,796 | 6,152 | 5,831 | 5,564 | 4,883 | 4,163 | 3,704 | 3,189 |
| Current Liabilities | 673 | 750 | 1,025 | 1,037 | 929 | 448 | 607 | 685 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||
| Total Equity | 4,727 | 4,258 | 3,618 | 3,298 | 2,821 | 2,176 | 1,968 | 1,720 |
| Share Capital | 403 | 402 | 401 | 401 | 400 | 400 | 200 | 200 |
| Reserves & Surplus | 4,324 | 3,856 | 3,217 | 2,897 | 2,421 | 1,776 | 1,768 | 1,520 |
Screen SYNGENE income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,037 | 892 | 926 | 933 | 840 | 908 | 962 | 1,017 | 832 | 932 | 883 | 773 | 660 | 784 | 803 |
| Expenses | 674 | 668 | 711 | 600 | 620 | 646 | 660 | 680 | 596 | 663 | 626 | 508 | 472 | 552 | 555 |
| EBITDA | 363 | 224 | 215 | 333 | 220 | 261 | 302 | 337 | 236 | 268 | 257 | 265 | 188 | 232 | 248 |
| Operating Profit % | 34.00% | 24.00% | 22.00% | 35.00% | 22.00% | 27.00% | 30.00% | 32.00% | 26.00% | 27.00% | 27.00% | 33.00% | 27.00% | 28.00% | 29.00% |
| Depreciation | 106 | 111 | 117 | 111 | 107 | 111 | 109 | 96 | 102 | 105 | 108 | 80 | 86 | 90 | 95 |
| Interest | 16 | 12 | 13 | 13 | 12 | 13 | 12 | 10 | 11 | 13 | 11 | 6 | 9 | 12 | 14 |
| Profit Before Tax | 241 | 101 | 85 | 209 | 101 | 137 | 181 | 231 | 123 | 151 | 138 | 179 | 93 | 130 | 140 |
| Tax | 57 | 15 | 18 | 20 | 26 | 31 | 50 | 52 | 30 | 34 | 27 | 31 | 19 | 28 | 30 |
| Net Profit | 183 | 87 | 67 | 189 | 76 | 106 | 131 | 179 | 93 | 117 | 112 | 148 | 74 | 102 | 110 |
| EPS | 4.56 | 2.16 | 1.67 | 4.70 | 1.89 | 2.64 | 3.27 | 4.36 | 2.33 | 2.90 | 2.78 | 3.71 | 1.85 | 2.55 | 2.74 |
Syngene International Cash Flow Screener - Liquidity Fundamentals
Screen SYNGENE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | 1,168 | 1,042 | 824 | 581 | 701 | 677 | 630 | 446 |
| Investing Activities | -744 | -495 | -653 | -611 | -629 | -424 | -646 | -349 |
| Financing Activities | -142 | -551 | -343 | -31 | 58 | -226 | -72 | -79 |
| Net Cash Flow | 281 | -4 | -172 | -62 | 130 | 28 | -88 | 18 |
Screen SYNGENE shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 52.74% | 52.68% | 52.68% | 54.79% | 54.72% | 54.72% | 52.74% | 54.88% |
| FII Holding | 19.47% | 16.50% | 16.31% | 20.92% | 20.63% | 20.72% | 20.64% | 0.02% |
| DII Holding | 21.50% | 24.05% | 24.62% | 15.80% | 16.80% | 17.48% | 19.53% | 10.73% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 5.08% | 5.59% | 5.28% | 6.45% | 6.08% | 5.45% | 5.59% | 8.39% |
| Other Holding | 1.21% | 1.18% | 1.10% | 2.03% | 1.77% | 1.62% | 1.50% | 25.98% |
| Shareholder Count | 125,090 | 142,310 | 136,061 | 115,850 | 120,018 | 107,338 | 128,806 | 124,014 |
Syngene International Dividend Screener - Share Yield Analysis
Screen SYNGENE dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹1.25 | 0.19% |
| 2024-March | ₹1.25 | 0.17% |
| 2023-March | ₹1.25 | 0.18% |
| 2022-March | ₹1.00 | 0.17% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.50 | 0.21% |
| 2018-March | ₹1.00 | 0.34% |
| 2017-March | ₹1.00 | 0.33% |
Syngene International Index Membership - Market Screener Classification
Screen SYNGENE by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Syngene International Market Events Screener - Corporate Actions
Screen SYNGENE market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2025-11-05 | 2025-11-05 | Quarterly Result Announcement | NA | 2.52% |
| 2025-07-23 | 2025-07-23 | Annual General Meeting | NA | -8.05% |
| 2025-07-23 | 2025-07-23 | Quarterly Result Announcement | NA | 6.63% |
| 2025-06-27 | 2025-06-27 | Dividend | ₹ 1.25 /share | -12.18% |
| 2025-04-23 | 2025-04-23 | Quarterly Result Announcement | NA | 5.45% |
| 2025-01-23 | 2025-01-23 | Quarterly Result Announcement | NA | -3.68% |
| 2024-10-23 | 2024-10-23 | Quarterly Result Announcement | NA | -5.14% |
| 2024-07-24 | 2024-07-24 | Annual General Meeting | NA | 8.09% |
| 2024-06-28 | 2024-06-28 | Dividend | ₹ 1.25 /share | 1.73% |
| 2023-06-30 | 2023-06-30 | Dividend | ₹ 0.50 /share | 21.36% |
| 2023-06-30 | 2023-06-30 | Dividend | ₹ 0.75 /share | 21.36% |
| 2022-06-30 | 2022-07-01 | Dividend | ₹ 0.50 /share | -11.59% |
| 2022-06-30 | 2022-07-01 | Dividend | ₹ 0.50 /share | -11.59% |
| 2019-06-11 | 2019-06-12 | Bonus | 1:1 | -1.09% |
Syngene International Competitors Screener - Peer Comparison
Screen SYNGENE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Syngene International | 26,199 | 55.90 | 3,714 | 3.77% | 496 | 51.46 |
| Indegene | 12,498 | 28.01 | 2,947 | 10.53% | 407 | 42.94 |
| Suven Life Sciences | 3,746 | -17.74 | 18 | -46.34% | -161 | 39.99 |
| Vimta Labs | 2,685 | 43.62 | 322 | 0.22% | 41 | 44.90 |
| Take Solutions | 597 | 12.37 | 10 | 126.67% | 1 | 87.87 |
| Bilcare | 185 | -4.17 | 807 | 4.78% | -56 | 43.28 |
| Jeevan Scientific Technology | 101 | -22.71 | 48 | 17.87% | 0 | 62.49 |
| Adeshwar Meditex | 26 | 33.09 | 84 | 5.00% | 2 | 21.16 |
| Vanta Bioscience | 17 | -1.26 | 2 | -78.57% | -13 | 20.40 |
Syngene International Company Announcements - News Screener
Screen SYNGENE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-05 | Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |
| 2026-01-02 | Closure of Trading Window | View |
| 2025-12-29 | Announcement under Regulation 30 (LODR)-Acquisition | View |
| 2025-12-17 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-12-15 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-12-11 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-12-08 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-12-08 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-12-02 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-27 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-27 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-26 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-26 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-26 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-25 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-24 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-24 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-24 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-18 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-11-17 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |